Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Brouchet

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Fundamental & Clinical Pharmacology|November 18, 2006
Understanding the oestrogen action in experimental and clinical atherosclerosisJ F Arnal, V Douin-Echinard, L Brouchet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implicationsF Andre, D Grunenwald, J P Pignon, et al.
Journal of Critical Care|October 27, 2017
3-month prognostic impact of severe acute renal failure under veno-venous ECMO support: Importance of time of onsetC Delmas, T Zapetskaia, J M Conil, et al.
European Journal of Endocrinology|February 7, 2004
Estrogens and atherosclerosisJ-F Arnal, P Gourdy, R Elhage, et al.
Oncogenesis|April 5, 2013
DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patientsC Allera-Moreau, I Rouquette, B Lepage, et al.
Annales De Chirurgie Plastique Et Esthetique|August 28, 2022
[Congenital thoracic deformities and 3D custom-made implants. New classification based on a series of 789 treated cases]J P Chavoin, F Facchini, V Martinot-Duquennoy, et al.
Revue Des Maladies Respiratoires|October 31, 2008
[Practical issues in the surgical treatment of non-small cell lung cancer. Recommendations from the French Society of Thoracic and Cardiovascular Surgery]P Thomas, M Dahan, M Riquet, et al.
Revue Des Maladies Respiratoires|March 19, 2013
[Evaluation of preoperative non-invasive ventilation in thoracic surgery for lung cancer: the preOVNI study GFPC 12-01]N Paleiron, M André, F Grassin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF)S Couraud, A B Cortot, L Greillier, et al.
Revue Des Maladies Respiratoires|January 28, 2014
[Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française]N Girard, V Gounant, B Mennecier, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Fundamental & Clinical Pharmacology|November 18, 2006
Understanding the oestrogen action in experimental and clinical atherosclerosisJ F Arnal, V Douin-Echinard, L Brouchet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implicationsF Andre, D Grunenwald, J P Pignon, et al.
Journal of Critical Care|October 27, 2017
3-month prognostic impact of severe acute renal failure under veno-venous ECMO support: Importance of time of onsetC Delmas, T Zapetskaia, J M Conil, et al.
European Journal of Endocrinology|February 7, 2004
Estrogens and atherosclerosisJ-F Arnal, P Gourdy, R Elhage, et al.
Oncogenesis|April 5, 2013
DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patientsC Allera-Moreau, I Rouquette, B Lepage, et al.
Annales De Chirurgie Plastique Et Esthetique|August 28, 2022
[Congenital thoracic deformities and 3D custom-made implants. New classification based on a series of 789 treated cases]J P Chavoin, F Facchini, V Martinot-Duquennoy, et al.
Revue Des Maladies Respiratoires|October 31, 2008
[Practical issues in the surgical treatment of non-small cell lung cancer. Recommendations from the French Society of Thoracic and Cardiovascular Surgery]P Thomas, M Dahan, M Riquet, et al.
Revue Des Maladies Respiratoires|March 19, 2013
[Evaluation of preoperative non-invasive ventilation in thoracic surgery for lung cancer: the preOVNI study GFPC 12-01]N Paleiron, M André, F Grassin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF)S Couraud, A B Cortot, L Greillier, et al.
Revue Des Maladies Respiratoires|January 28, 2014
[Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française]N Girard, V Gounant, B Mennecier, et al.
Pageof 3